According to the latest report by IMARC Group, titled, “Cloning & Mutagenesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global cloning & mutagenesis market size reached US$ 2.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.4 Billion by 2028, exhibiting a growth rate (CAGR) of 17.3% during 2023-2028.
Cloning and mutagenesis refer to two crucial techniques used in the field of biotechnology. Cloning represents the process of making an identical copy of a Deoxyribonucleic Acid (DNA) sequence, typically using a vector (including a plasmid) to insert the sequence into a host organism (such as bacteria). On the other hand, mutagenesis is often utilized to study the function of specific genes or to create new variants with altered properties. In recent times, these important techniques have gained traction as they are critical tools that have revolutionized numerous areas of biotechnology and have enabled researchers to study genes and proteins for the development of novel therapeutics, agricultural products, and industrial processes.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/cloning-mutagenesis-market/requestsample
Cloning & Mutagenesis Market Trends and Drivers:
The growing prevalence of chronic and genetic disorders across the globe is primarily driving the cloning and mutagenesis market. Furthermore, the escalating demand for personalized medicines as they involve tailoring medical treatment to an individual genetic makeup, which is performed through these crucial techniques, is also augmenting the market growth. Apart from this, the widespread adoption of cloning and mutagenesis in the biotechnology and pharmaceutical industries to develop new drugs, vaccines, and therapeutic proteins is positively influencing the global market. Moreover, several advancements in genetic engineering technologies that have made these important techniques more efficient, precise, and cost-effective are further bolstering the market growth. Besides this, the increasing applications of genetically modified organisms (GMOs) in agriculture for producing insect-resistant and herbicide-tolerant seeds and in the medical industry are acting as significant growth-inducing factors. Additionally, government bodies of various countries and private organizations are investing in research and development (R&D) in the biotechnology field, which is expected to drive the cloning and mutagenesis market.
Cloning & Mutagenesis Market 2023-2028 Competitive Analysis and Segmentation:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
- ABM Industries Inc.
- Agilent Technologies Inc.
- Assay Genie Limited
- Bio-Rad Laboratories Inc.
- Charles River Laboratories International Inc. (Bausch & Lomb)
- Genewiz Inc (Azenta Life Sciences)
- Jena Bioscience GmbH
- Merck KGaA
- New England Biolabs Inc.
- Promega Corporation
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
- TransGen Biotech Co. Ltd., etc.
The report has segmented the market based on product, technology, and end user.
- Cloning Kits
- Mutagenesis Kits
- Topo PCR Cloning
- Blunt End Cloning
- Seamless Cloning
- Site-directed Mutagenesis
End User Insights:
- Biopharmaceutical and Pharmaceutical Companies
- CROs and CMOs
- Academic and Research Institutes
Breakup by Region:
- North America
- Latin America
- Middle East and Africa
Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=8110&flag=C
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact us: IMARC Group Email: email@example.com USA: +1-631-791-1145 | Asia: +91-120-433-0800 Address: 134 N 4th St. Brooklyn, NY 11249, USA Website: https://www.imarcgroup.com/ Follow us on Twitter: @imarcglobal Linkedin: https://www.linkedin.com/company/imarc-group